PINPOINT enables non-destructive nanoscopic quality control of individual lipid nanoparticles and their mRNA cargo

Modern medicine has entered an era where the body's own instructions, written in a molecule called messenger RNA, can be used to teach cells how to fight disease or replace missing proteins. To deliver these fragile instructions safely into the human body, scientists wrap them in tiny, microscopic bubbles made of fat, known as lipid nanoparticles. These bubbles act as protective vehicles, shielding the genetic cargo from the harsh environment outside the cell and guiding it to the right destination. The success of vaccines and other new therapies depends entirely on these vehicles being built correctly: they must be the right size, hold the right amount of medicine, and keep that medicine intact. However, checking the quality of these billions of tiny bubbles has been like trying to judge the contents of a sealed box by weighing the whole pile; standard tests measure the average of the entire batch, hiding the fact that some bubbles might be empty, some might be broken, and others might be carrying too much or too little medicine.

A team of researchers at the University of Michigan has developed a new way to look inside these bubbles without breaking them open. They call their method PINPOINT, a technique that allows scientists to examine individual nanoparticles one by one, seeing their shape and checking exactly what is inside. Instead of grinding up a sample to get an average reading, this approach uses a special microscope to watch single particles sitting on a glass slide. The researchers first take a picture of the bubble's outer shell using a dye that glows when it touches fat, revealing the particle's size and whether it is perfectly round or misshapen. Then, they gently poke a tiny, temporary hole in the bubble's wall using a very mild soap-like substance. This hole is just big enough to let a probe reach inside and touch the genetic cargo, but small enough that the bubble stays whole and does not fall apart.

Once the probe can reach inside, it acts like a specific key that only fits a particular lock. The researchers used short strands of DNA designed to bind only to the specific genetic message they were looking for. Because the genetic instructions inside the bubble are often folded up tightly, the team also added helper strands of DNA to smooth out the folds and make the message easier to find. When the probe finds its match, it lights up and then lets go, repeating this process many times. By watching how often the probe binds and how long it stays attached, the researchers can confirm the identity of the cargo and even tell if the message is whole or broken. This method revealed that even in batches that look uniform on the surface, there is a surprising amount of variety: some particles are empty, some carry multiple copies of the message, and some have shapes that change after being frozen and thawed.

The study showed that this new method can detect differences that traditional tests miss. For example, when the researchers stressed the nanoparticles by freezing and thawing them, standard tests only saw a slight change in the average size. But the new method showed that a significant number of particles had become misshapen and were no longer perfect circles, a detail that could affect how well they work in the body. It also allowed the team to count how many copies of the genetic message were inside each bubble, finding that the number varied from particle to particle. In one experiment, they found that only about sixty percent of the bubbles actually contained the genetic message they were supposed to carry, while the rest were empty. This level of detail provides a much clearer picture of what is really happening inside a batch of medicine.

By combining a view of the particle's shape with a check of its contents, this technique offers a powerful new tool for ensuring the quality of these life-saving treatments. It does not require destroying the sample or using complex chemical reactions to amplify the signal, meaning the results reflect the true state of the particles as they are. While the current method is not yet fast enough for checking every single dose on a factory line, it provides a detailed map of what goes wrong when a batch is imperfect. This insight helps scientists understand why some batches work better than others and guides the design of better delivery systems for the future. The ability to see the individual variations within a crowd of billions transforms a hidden problem into a measurable fact, offering a path toward more consistent and effective treatments.